Development of a Patient-Level Multi-objective Optimisation Model for Screening Strategies for Childhood Type 1 Diabetes - PharmacoEconomics Objective To develop a patient-level simulation model of type 1 diabetes (T1D) covering both childhood and adulthood. The goal is to identify and evaluate the cost-effectiveness of optimal screening f...

Our new microsimulation model to optimise T1D screening by balancing cost, pragmatism, and reduced diabetic ketoacidosis is out. #T1D #T1Dscreening doi.org/10.1007/s402...

Join experts Dr Rachel Besser and Dr Victoria Salem on the 30th October, for an in-depth session on type 1 diabetes screening.

Covering rationale, emerging approaches & staging. Gain practical insight for clinical use.

Register 🔗 ow.ly/vf7Q50X6WtU

#T1DScreening #T1DM

The efficacy of islet autoantibody screening with and without genetic pre-screening to identify early-stage #T1D – it boils down to maximising participation. #T1Dscreening #DiabetesResearch @edent1fi.bsky.social 🔓link.springer.com/article/10.1007/s00125-0...

Precision medicine in stage 2 #T1D - C Mathieu

Conclusion ⤵️

#ATTD2025 #dedoc° #NothingAboutUsWithoutUs #T1Dscreening #diabetes

EDENT1FI at the BR1DGE Summit in Sitges! We're here with a strong EDENT1FI presence! Our industry partner Sanofi is doing a great job educating HCPs on screening for early-T1D.
#T1DScreening #BR1DGE
EDENT1FI (edent1fi.bsky.social)
Innovative Health Initiative (innovativehealthinitiative.bsky.social)

Preventing complications starts with early action. Projects like Hypo-Resolve and BEAt-DKD show the innovation in tackling diabetes challenges. At EDENT1FI, we share this vision: screening for type 1 diabetes early to prevent severe outcomes like DKA.

#T1DScreening #DiabetesResearch #EDENT1FI